ERBB2 and breast carcinoma: McLarty et al. reported that the tumor uptake of 111In-DTPA-trastuzumab, after correcting for nonspecific IgG accumulation and circulating radioactivity, exhibited strong nonlinear associations with the HER2 density in a mouse model of breast cancer [29].